MD Anderson Cancer Center: Clinical Trials & Research Profile

Academic / Cooperative Group (Houston, TX) · Primary Focus: Oncology and Hematology

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationAcademic / Cooperative Group (Houston, TX)
Primary Therapeutic AreaOncology and Hematology
Active Phase II & III Studies344 active (201 recruiting now)
Total Tracked Studies (2018 to 2026)519 (4 with California sites)
Completed vs Early-Stopped Studies38 completed / 137 stopped (26.4% stop rate)
Median Closed Enrollment24 participants
FDA Drugs@FDA Original Approvals0 all-time (0 from 2018 to 2026)
Physical Hospital Site Disclosure100.0% named hospital slots

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for MD Anderson Cancer Center across sibling Meru public-data platforms.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk